Last reviewed · How we verify
NCT07056530: TELENURSING-HT
Effectiveness of Telenursing on Self-Care and Blood Pressure Control in Adults With Hypertension
NA trial testing Telenursing Counseling in Hypertension in 151 participants. Completed in 1 June 2025.
22 March 2025
Quick facts
| Lead sponsor | Dursun Alper YILMAZ |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | non randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | health services research |
| Enrollment | 151 |
| Start date | 22 March 2024 |
| Primary completion | 22 March 2025 |
| Estimated completion | 1 June 2025 |
| Sites | 1 location across Turkey (Türkiye) |
Drugs / interventions tested
- Telenursing Counseling
Conditions studied
- Hypertension — all drugs for Hypertension →
- Nursing — all drugs for Nursing →
- Telenursing — all drugs for Telenursing →
Sponsor
Dursun Alper YILMAZ
Who can join
Adults 30 to 75, any sex, with Hypertension or Nursing. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This quasi-experimental study aims to evaluate the effectiveness of a structured telenursing program in improving self-care practices and blood pressure control among adults with chronic hypertension in Türkiye. Participants received weekly telephone-based nursing counseling for eight weeks, focusing on medication adherence, healthy nutrition, physical activity, stress management, and regular self-monitoring. The study compares changes in blood pressure and self-care scores between the intervention and control groups.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT07056530
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Hypertension
Currently open trials in the same condition.
- NCT07413159 — The "Check, Monitor, Control Hypertension" Study is a 24-month Randomized Trial in Houston Targeting African Americans A · NA · recruiting
- NCT07361276 — Observational Study That Will Evaluate Treatment Patterns in the Management of Hypertension in the Public Primary Care S · recruiting
- NCT07238556 — A Novel Digital Tool Physicians Can Use to Prescribe Exercise to Patients With Cardiovascular Disease Risk Factors · NA · recruiting
- NCT07238400 — Cardiac Effects of Mineralocorticoid Receptor Antagonism After Preeclampsia · Phase 2 · recruiting
- NCT07135505 — Early Time-Restricted Eating in Older Adults With Hypertension · NA · recruiting
Other Dursun Alper YILMAZ trials
Trials by the same sponsor.
- NCT07194681 — Adolescent Nutrition and Eating Behaviors in Türkiye · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07056530 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Dursun Alper YILMAZ
- Last refreshed: 9 July 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07056530.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing